We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$4.37B
AUM Growth
-$127M
Cap. Flow
-$302M
Cap. Flow %
-6.91%
Top 10 Hldgs %
18.33%
Holding
143
New
6
Increased
13
Reduced
119
Closed
5

Sector Composition

Rank Sector Weight
1 Industrials 19.84%
2 Technology 17.79%
3 Healthcare 16.55%
4 Financials 14.61%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTL icon
51
Unitil
UTL
$969M
$34.2M 0.78%
645,802
-51,887
-7% -$2.79M
PACW
52
DELISTED
PacWest Bancorp
PACW
$33.7M 0.77%
819,711
-42,171
-5% -$1.8M
SLRC icon
53
SLR Investment Corp
SLRC
$685M
$33.3M 0.76%
1,788,180
-112,723
-6% -$2.11M
SUPN icon
54
Supernus Pharmaceuticals
SUPN
$2.59B
$32.7M 0.75%
1,061,653
+88,360
+9% +$2.71M
TCBI icon
55
Texas Capital Bancshares
TCBI
$4.31B
$32.6M 0.75%
513,179
-27,850
-5% -$1.88M
WSC icon
56
WillScot Mobile Mini Holdings
WSC
$4.42B
$32.5M 0.74%
1,167,306
-68,176
-6% -$1.96M
KRA
57
DELISTED
Kraton Corporation
KRA
$32.4M 0.74%
1,004,358
-346,749
-26% -$12.2M
WWE
58
DELISTED
World Wrestling Entertainment
WWE
$31.6M 0.72%
546,678
+7,201
+1% +$409K
BBT
59
Beacon Financial Corp
BBT
$2.63B
$30.9M 0.71%
1,127,541
-68,400
-6% -$1.74M
MRCY icon
60
Mercury Systems
MRCY
$5.82B
$30.9M 0.71%
465,452
+68,138
+17% +$4.71M
VBTX
61
DELISTED
Veritex Holdings
VBTX
$30.1M 0.69%
849,561
-67,203
-7% -$2.35M
WAB icon
62
Wabtec
WAB
$49.4B
$30M 0.69%
364,222
-24,979
-6% -$2.03M
VOYA icon
63
Voya Financial
VOYA
$9.04B
$29.5M 0.67%
479,253
-26,724
-5% -$1.76M
NOVT icon
64
Novanta
NOVT
$5.12B
$29.4M 0.67%
218,488
-68,134
-24% -$9.17M
CTLT
65
DELISTED
CATALENT, INC.
CTLT
$29.2M 0.67%
270,454
-6,912
-2% -$741K
B
66
DELISTED
Barnes Group Inc.
B
$29.2M 0.67%
569,246
-33,786
-6% -$1.75M
CHCT
67
Community Healthcare Trust
CHCT
$525M
$29.2M 0.67%
614,653
-50,615
-8% -$2.48M
SLGN icon
68
Silgan Holdings
SLGN
$4.26B
$29M 0.66%
698,914
-45,673
-6% -$1.94M
BY icon
69
Byline Bancorp
BY
$1.78B
$28.8M 0.66%
1,270,737
-78,942
-6% -$1.77M
USX
70
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$28.4M 0.65%
3,298,991
-260,131
-7% -$2.77M
IWN icon
71
iShares Russell 2000 Value ETF
IWN
$14.3B
$27.8M 0.64%
167,457
-13,518
-7% -$2.23M
CHRS icon
72
Coherus Oncology
CHRS
$219M
$27.5M 0.63%
1,990,443
-111,244
-5% -$1.58M
SP
73
DELISTED
SP Plus Corporation
SP
$27.5M 0.63%
899,050
-71,240
-7% -$2.33M
CWST icon
74
Casella Waste Systems
CWST
$5.68B
$27.4M 0.63%
432,242
-34,728
-7% -$2.3M
DBI icon
75
Designer Brands
DBI
$309M
$26.6M 0.61%
1,609,630
-100,915
-6% -$1.78M

Similar funds

Aristotle Capital Boston's Q2 2021 Portfolio in Review

As of Q2 2021, Aristotle Capital Boston held 143 positions worth $4.37B, down 2.8% from $4.49B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Aristotle Capital Boston withdrew a net $302M in Q2 2021, closing 5 positions and reducing 119 holdings. Its most notable exit was HMS Holdings Corp., an estimated $74.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aristotle Capital Boston opened a new position in Huntington Bancshares worth $35.4M.

  • Aristotle Capital Boston's largest Q2 2021 buy was Huntington Bancshares: 2,477,203 shares worth $35.4M.
  • Aristotle Capital Boston added most to Box in Q2 2021, an estimated $12.7M increase.
  • Aristotle Capital Boston's biggest Q2 2021 reduction was Gartner, cutting an estimated $13.4M.
  • Aristotle Capital Boston fully exited HMS Holdings Corp. in Q2 2021, selling an estimated $74.5M.
  • Aristotle Capital Boston's ten largest holdings make up 18% of its $4.37B portfolio in Q2 2021.
  • Aristotle Capital Boston opened 6 new positions and closed 5 in Q2 2021.
  • Aristotle Capital Boston's portfolio value fell 2.8% quarter-over-quarter to $4.37B.

Based on Aristotle Capital Boston's 13F filing for Q2 2021, filed 16 Aug 2021.